[1]
Sher, A. and Wu, S. 2011. Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy–A meta-analysis. Acta Oncologica. 50, 7 (Oct. 2011), 997–1005. DOI:https://doi.org/10.3109/0284186X.2011.581689.